rs189773500

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_003978.5(PSTPIP1):​c.908C>T​(p.Pro303Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0005 in 1,604,630 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0027 ( 3 hom., cov: 33)
Exomes 𝑓: 0.00027 ( 2 hom. )

Consequence

PSTPIP1
NM_003978.5 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.504
Variant links:
Genes affected
PSTPIP1 (HGNC:9580): (proline-serine-threonine phosphatase interacting protein 1) This gene encodes a cytoskeletal protein that is highly expressed in hemopoietic tissues. This protein functions via its interaction with several different proteins involved in cytoskeletal organization and inflammatory processes. It binds to the cytoplasmic tail of CD2, an effector of T cell activation and adhesion, downregulating CD2-triggered adhesion. It binds PEST-type protein tyrosine phosphatases (PTP) and directs them to c-Abl kinase to mediate c-Abl dephosphorylation, thereby, regulating c-Abl activity. It also interacts with pyrin, which is found in association with the cytoskeleton in myeloid/monocytic cells and modulates immunoregulatory functions. Mutations in this gene are associated with PAPA (pyogenic sterile arthritis, pyoderma gangrenosum, and acne) syndrome. It is hypothesized that the disease-causing mutations compromise physiologic signaling necessary for the maintenance of a proper inflammatory response. [provided by RefSeq, Mar 2016]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0059553683).
BP6
Variant 15-77032931-C-T is Benign according to our data. Variant chr15-77032931-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 138828.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-77032931-C-T is described in Lovd as [Likely_benign].
BS2
High AC in GnomAd4 at 409 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PSTPIP1NM_003978.5 linkuse as main transcriptc.908C>T p.Pro303Leu missense_variant 12/15 ENST00000558012.6 NP_003969.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PSTPIP1ENST00000558012.6 linkuse as main transcriptc.908C>T p.Pro303Leu missense_variant 12/151 NM_003978.5 ENSP00000452746 P3O43586-1

Frequencies

GnomAD3 genomes
AF:
0.00268
AC:
408
AN:
152144
Hom.:
3
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00922
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.000667
AC:
155
AN:
232494
Hom.:
1
AF XY:
0.000433
AC XY:
55
AN XY:
126954
show subpopulations
Gnomad AFR exome
AF:
0.0101
Gnomad AMR exome
AF:
0.000511
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000572
Gnomad SAS exome
AF:
0.0000348
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000958
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000271
AC:
393
AN:
1452368
Hom.:
2
Cov.:
31
AF XY:
0.000213
AC XY:
154
AN XY:
721580
show subpopulations
Gnomad4 AFR exome
AF:
0.00912
Gnomad4 AMR exome
AF:
0.000731
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000354
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000126
Gnomad4 OTH exome
AF:
0.000650
GnomAD4 genome
AF:
0.00269
AC:
409
AN:
152262
Hom.:
3
Cov.:
33
AF XY:
0.00269
AC XY:
200
AN XY:
74438
show subpopulations
Gnomad4 AFR
AF:
0.00922
Gnomad4 AMR
AF:
0.00131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.000843
Hom.:
1
Bravo
AF:
0.00326
ESP6500AA
AF:
0.0105
AC:
41
ESP6500EA
AF:
0.000242
AC:
2
ExAC
AF:
0.000659
AC:
79

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Pyogenic arthritis-pyoderma gangrenosum-acne syndrome Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesJan 04, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingGeneDxDec 28, 2012This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
PSTPIP1-related disorder Benign:1
Benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJan 31, 2020This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.50
CADD
Benign
13
DANN
Uncertain
0.98
DEOGEN2
Benign
0.36
T;.
Eigen
Benign
-0.58
Eigen_PC
Benign
-0.57
FATHMM_MKL
Benign
0.24
N
LIST_S2
Benign
0.71
T;T
MetaRNN
Benign
0.0060
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.97
L;.
MutationTaster
Benign
1.0
D;D;N;N
PrimateAI
Uncertain
0.51
T
PROVEAN
Uncertain
-2.4
N;N
REVEL
Benign
0.14
Sift
Benign
0.036
D;D
Sift4G
Benign
0.44
T;T
Polyphen
0.47
P;.
Vest4
0.25
MVP
0.73
MPC
0.15
ClinPred
0.020
T
GERP RS
4.8
Varity_R
0.052
gMVP
0.51

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs189773500; hg19: chr15-77325272; API